Policy and Medicine March 2022 Issue Features FDA Exclusivity, Baby Powder,…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Author
California is the Latest State to Settle with Centene Over Overpayment…
California Attorney General Rob Bonta recently announced a $215,392,758 settlement with Centene Corporation and its subsidiaries…
MGMA Submits Comments to CMS in Support of Prior Authorization Reforms
The Medical Group Management Association (MGMA) submitted comments to Centers for Medicare and Medicaid Services (CMS)…
Fiscal Year 2022 False Claims Act Settlements and Judgments Exceed $2…
In the Fiscal Year ending September 30, 2022, settlements and judgments under the False Claims Act exceeded $2.2 billion. That…
Alliance for Connected Care Calls for Telehealth Flexibility Extension
With the COVID-19 public health emergency (PHE) set to expire on May 11, 2023, the Alliance for Connected Care wrote a letter to…
DEA Proposes Making Telemedicine Flexibilities Permanent
The Drug Enforcement Administration (DEA) recently announced making permanent changes to the rules for prescribing controlled…
Could Simplified Clinical Trials Lead to More Diversity?
During comments made at the 2023 Innovations in Regulatory Science Summit, Food and Drug Administration (FDA) Center for Drug…
GoodRx Fined in First Violation of the Health Breach Notification Rule
The United States Federal Trade Commission (FTC) filed a proposed order with the Department of Justice (DOJ) regarding GoodRx…
Walgreens to Pay $83 Million in West Virginia Opioid Settlement
West Virginia and Walgreens reached an $83 million settlement, resolving claims over Walgreens’ role in perpetuating the opioid…
Pfizer Loses Anti-Kickback Case at SCOTUS
We previously wrote about the petition Pfizer filed at the Supreme Court of the United States (SCOTUS), seeking the reversal of a…